Standard Clinical Research

COMPASS Pathways Clinical Trial Network

Location: Multiple US Sites,

Hours: Trial enrollment by application

Research / clinical trialPublic source listedReviewed 2026-05-21

About COMPASS Pathways Clinical Trial Network

COMPASS Pathways is a pharmaceutical company running Phase 3 trials of COMP360 (synthetic psilocybin) for treatment-resistant depression across multiple US sites. Their Phase 3 interim data showed significant effect versus placebo in TRD. NDA submission expected late 2026 with FDA approval possible 2027-2028. If approved, COMP360 would be the first FDA-approved psilocybin product.

Location & Legal Context

COMPASS Pathways Clinical Trial Network operates in Multiple US Sites. Before visiting or purchasing, review the psilocybin laws in Multiple US Sites to understand the current legal landscape.

How We Classify This Listing

Service modelResearch / clinical trial
JurisdictionMultiple US Sites
Review statusPublic source listed
Last reviewed2026-05-21

Directory listings are informational, not endorsements. For regulated psilocybin services, verify licensing with the relevant state program before booking or paying.

Community Reviews

Community reviews coming in Phase 2. Have you worked with COMPASS Pathways Clinical Trial Network? Share your experience in the forum.

LearnShrooms lists vendors for informational purposes. Verify legality in your jurisdiction before purchasing. Vendors are responsible for their own legal compliance. Check Multiple US Sites laws →